Kestra Advisory Services »

Phathom Pharmaceuticals shares owned by Kestra Advisory Services

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Kestra Advisory Services from 13F filings

Historical chart of Kestra Advisory Services investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Kestra Advisory Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $38k 2.3k 16.59

More positions owned by Kestra Advisory Services

Apple (AAPL)
NVIDIA Corporation (NVDA)
Parker-Hannifin Corporation (PH)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Vanguard Index Fds Total Stk Mkt (VTI)
First Tr Exchange Traded Risng Divd Achiv (RDVY)

View all positions for Kestra Advisory Services

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Millennium Management
Invesco
BlackRock
Carlyle
Vanguard Group
Ensign Peak Advisors
NEA Management Company
683 Capital Management
Catalys Pacific
Daniel D. Thurber
Jennifer Ranahan
State Street Corporation
Geode Capital Management

View all funds holding Phathom Pharmaceuticals